Correlation Between FibroGen and Companhia Siderrgica

Can any of the company-specific risk be diversified away by investing in both FibroGen and Companhia Siderrgica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FibroGen and Companhia Siderrgica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FibroGen and Companhia Siderrgica Nacional, you can compare the effects of market volatilities on FibroGen and Companhia Siderrgica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FibroGen with a short position of Companhia Siderrgica. Check out your portfolio center. Please also check ongoing floating volatility patterns of FibroGen and Companhia Siderrgica.

Diversification Opportunities for FibroGen and Companhia Siderrgica

-0.37

Correlation Coefficient

FibroGen  Companhia Siderrgica

Very good diversification

The 3 months correlation between FibroGen and Companhia is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and Companhia Siderrgica Nacional in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Companhia Siderrgica and FibroGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FibroGen are associated (or correlated) with Companhia Siderrgica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Companhia Siderrgica has no effect on the direction of FibroGen i.e., FibroGen and Companhia Siderrgica go up and down completely randomly.

Pair Corralation between FibroGen and Companhia Siderrgica

Assuming the 90 days trading horizon FibroGen is expected to under-perform the Companhia Siderrgica. In addition to that, FibroGen is 1.55 times more volatile than Companhia Siderrgica Nacional. It trades about -0.03 of its total potential returns per unit of risk. Companhia Siderrgica Nacional is currently generating about 0.01 per unit of volatility. If you would invest  3,756  in Companhia Siderrgica Nacional on September 14, 2024 and sell it today you would lose (56.00) from holding Companhia Siderrgica Nacional or give up 1.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

FibroGen  vs.  Companhia Siderrgica Nacional

FibroGen

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FibroGen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Companhia Siderrgica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Companhia Siderrgica Nacional has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Companhia Siderrgica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with FibroGen and Companhia Siderrgica

The main advantage of trading using opposite FibroGen and Companhia Siderrgica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FibroGen position performs unexpectedly, Companhia Siderrgica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Companhia Siderrgica will offset losses from the drop in Companhia Siderrgica's long position.

The idea behind FibroGen and Companhia Siderrgica Nacional pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.